Germline Missense Variants in <i>BRCA1</i>: New Trends and Challenges for Clinical Annotation
Genetic testing allows for the identification of germline DNA variations, which are associated with a significant increase in the risk of developing breast cancer (BC) and ovarian cancer (OC). Detection of a <i>BRCA1</i> or <i>BRCA2</i> pathogenic variant triggers several cli...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2019-04-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/11/4/522 |